Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Report Overview
2023
Base Year
2017-2023
Historical Year
2024-2032
Forecast Year
Global Age-Related Macular Degeneration (AMD) Market Outlook
The global age-related macular degeneration (AMD) market stood at USD 2.04 billion in 2023 and is projected to reach USD 4.40 billion by 2032, growing at CAGR of 8.9% between 2024 and 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The age-related macular degeneration (AMD) is a disease in which the macula of the eye’s small central region of the retina deteriorates. The macula is considered to be an essential component of the retina, as it regulates the visual perception of the eye. The ability of an individual to read, identify and recognize objects that require immaculate visual details determine macular health.
Market Segmentation
Usually, after the age of sixty, there is an onset of an eye disease that can gradually destroy the macula, the middle part of the retina, further impairing the central vision of the eye. Age-related macular degeneration (AMD) causes rare blindness as it affects the centre of the eye.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The age-related macular degeneration (AMD) industry can be divided based on segments such as product, drug, route of administration, and region.
The industry can be broadly categorised on the basis of product into:
- Wet AMD
- Dry AMD
The industry can be divided based on the drug into:
- Lucentis
- Eylea
- Avastin
- Others
The industry can be divided on the basis of route of administration into:
- Intravenous
- Intravitreal
The EMR report looks into the regional markets of age-related macular degeneration (AMD) like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific regions.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
The enhanced reimbursement incentives for age-related macular degeneration (AMD) drugs add to the development of the industry. In addition, the age-related macular degeneration market is driven by an increase in the incidence of eye-related disorders and growth in the global geriatric population. Although the growing use of off-label medications and the availability of off-label treatments hinder the industry growth, the rising market trends, such as the advancement of gene therapy for age-related macular degeneration, will result in the growth of the medical therapy of age-related macular degeneration.
Just a few licensed drugs are available for the treatment of the disorder in the market. The related side-effects are also severe to the consumer’s health. Therefore, the need for safe and innovative drugs to treat age-related macular degeneration remains substantially unmet. This has culminated in several drug firms focusing on gene therapy to treat the disease. Intravitreal injection administered gene therapy does not affect the cells. It also protects and enhances the vision of patients. Such advantages will drive demand for gene therapy, which during the forecast period, will have a positive impact on the industry growth globally.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global age-related macular degeneration (AMD) market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Bayer AG
- F. Hoffmann-La Roche Ltd.
- Regeneron Pharmaceuticals Inc. (NASDAQ: REGN)
- Novartis AG
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment
|
| Breakup by Product |
|
| Breakup by Drug |
|
| Breakup by Route of Administration |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Key Questions Answered in the Report
In 2023, the global age-related macular degeneration (AMD) market attained a value of nearly USD 2.04 billion.
The market is projected to grow at a CAGR of 8.9% between 2024 and 2032.
The market is estimated to witness a moderate growth in the forecast period of 2024-2032 to reach about USD 4.40 billion by 2032.
The major drivers of the industry, such as the enhanced reimbursement policies, increasing prevalence of eye-related disorders amongst the geriatric population, increasing demand for enhanced healthcare facilities, and the growing technological advancements, are expected to aid the market growth.
The key market trends guiding the growth of the age-related macular degeneration (AMD) industry include the growing preference for intravitreal injection administered gene therapy and increasing clinical trials.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Wet AMD and dry AMD are the leading products of age-related macular degeneration (AMD) in the industry.
The major drug segments in the industry include Lucentis, Eylea, and Avastin, among others.
The significant routes of administration available in the industry include intravenous and intravitreal.
The major players in the industry are Bayer AG, F. Hoffmann-La Roche Ltd., Novartis AG, and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN), among others.
Purchase Full Report
Datasheet
- Selected Sections, One User
- Printing Not Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Single User License
One User
- All Sections, One User
- One Print Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
Five Users
- All Sections, Five Users
- Five Prints Allowed
- Email Delivery in PDF
- Free Limited Customisation
- Post Sales Analyst Support
50% Discount on Next Update
Corporate License
Unlimited Users
- All Sections, Unlimited Users
- Unlimited Prints Allowed
- Email Delivery in PDF + Excel
- Free Limited Customisation
- Post Sales Analyst Support
- 50% Discount on Next Update
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Subscribe to our Newsletter
By subscribing you agree to with our privacy policy and provide
consent to
receive
updates
from our company.
Our Offices
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124